A sample of Nandrolone Decanoate (Oil sample 2), manufactured by QSC, was submitted for independent analysis to determine its potency. The sample was submitted by MAD66, and the analysis was funded by the same individual. Testing was carried out by Janoshik Analytical, a laboratory specializing in the evaluation of pharmaceutical-grade anabolic substances.
The measured concentration of 186.91 mg/ml was found against a label claim that is unspecified in the report, but commonly assumed to be 200 mg/ml for similar preparations. This would indicate a 6.55% underdose, placing it just within the general tolerance range for pharmaceutical variance.
This test adds to the growing body of consumer-funded analyses that aim to ensure accountability in underground performance enhancement products.
Detailed Report
Product Overview
- Manufacturer: QSC
- Product Name: Nandrolone Decanoate (Oil sample 2)
- Active Ingredient: Nandrolone Decanoate
- Batch Number: Unknown
- Expiration Date: Not Provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #63755
- Testing Ordered: 23 April 2025
- Sample Received: 29 April 2025
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: MAD66 (Individual)
- Analysis Paid For By: MAD66 (Individual)
Testing Results
| Component/Test | Specification (Label Claim) | Measured Concentration | Accuracy | Variance |
|---|---|---|---|---|
| Nandrolone Decanoate | 200 mg/ml* | 186.91 mg/ml | 93.45% | -6.55% |
*Estimated label claim used for evaluation purposes.
Verification Details
- Verification URL: https://janoshik.com/tests/63755_MF3C4BVRR8K5
Evaluation of Independent Testing
The independently submitted and funded analysis of this sample revealed a potency of 186.91 mg/ml, which would constitute a 6.55% underdose if the intended concentration was 200 mg/ml. This level of deviation is modest and may still fall within accepted pharmaceutical tolerances, but it does highlight the importance of external quality checks in non-pharmaceutical distribution channels.
The fact that the sample was submitted and funded by an individual consumer, MAD66, and not affiliated with the manufacturer or a reseller, increases the credibility and impartiality of this analysis.
Conclusion
This third-party lab analysis of QSC’s Nandrolone Decanoate reveals a 6.55% underdose (assuming a 200 mg/ml label claim), with a measured concentration of 186.91 mg/ml. Though the deviation is not extreme, it underscores the importance of routine independent testing to validate dosing accuracy and ensure consumer protection.
Continued user-funded testing of multiple batches remains essential for verifying consistency across production runs and exposing possible quality control lapses.
Disclaimer
This report is for educational and harm reduction purposes. While individual testing efforts such as this one offer valuable insight, they reflect only a single batch and may not be representative of overall product quality. Repeated testing across time and batches is strongly recommended for any consistent assessment.
